Human Insulin Market by Drugs & Applications Human Insulin Market by Drugs & Applications | Page 25

SAMPLE TABLES TABLE 1 LONG-ACTING INSULIN ANALOGS AND BIOSIMILARS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 2013 2014 2015-e 2020-p CAGR (2015–2020) NORTH AMERICA xx.x xx.x xx.x xx.x xx.x % EUROPE xx.x xx.x xx.x xx.x xx.x % ASIA-PACIFIC xx.x xx.x xx.x xx.x xx.x % ROW xx.x xx.x xx.x xx.x xx.x % TOTAL xx.x xx.x xx.x xx.x xx.x % REGION Sources: WHO, OECD, EHN, the World Bank, U.S. Census Bureau, Offices of National Statistics (U.K.), Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis TABLE 2 U.S.: HUMAN INSULIN DRUGS MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION) 2013 2014 2015-e 2020-p CAGR (2015–2020) INSULIN ANALOGS & BIOSIMILARS xx.x xx.x xx.x xx.x xx.x % HUMAN INSULIN BIOLOGICS xx.x xx.x xx.x xx.x xx.x % TOTAL xx.x xx.x xx.x xx.x xx.x % PRODUCT Sources: WHO, OECD, EHN, the World Bank, U.S. Census Bureau, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis TABLE 3 EUROPE: HUMAN INSULIN MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION) 2013 2014 2015-e 2020-p CAGR (2015–2020) GERMANY xx.x xx.x xx.x xx.x xx.x % FRANCE xx.x xx.x xx.x xx.x xx.x % U.K. xx.x xx.x xx.x xx.x xx.x % ROE xx.x xx.x xx.x xx.x xx.x % TOTAL xx.x xx.x xx.x xx.x xx.x % COUNTRY/REGION Sources: WHO, OECD, EHN, the World Bank, Offices of National Statistics (U.K.), Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis [email protected] www.marketsandmarkets.com 25